Tokyo, Aug. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062715) titled 'Single-arm phase II study evaluating supportive therapy for patients with non-small cell lung cancer receiving immune checkpoint inhibitor plus chemotherapy using Juzentaihoto: SUPPORT-JTT study' on Aug. 27.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - University of Toyama
Condition:
Condition - non-small cell lung cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The present study aims to evaluate the efficacy of Ju...